natgillin/translations-raw huggingface dataset:
In addition, the corresponding frequency category for each adverse drug reaction is based on the following convention (CIOMS III): very common (≥1/10); common (≥1/100 to <1/10); uncommon (≥1/1,000 to <1/100); rare (≥1/10,000 to <1/1,000); very rare (<1/10,000); not known (cannot be estimated from the available data).
Uz to, odgovarajuća kategorija učestalosti za svaku nuspojavu temelji se na sljedećoj konvenciji (CIOMS III): vrlo često (≥ 1/10); često (≥ 1/100 i < 1/10); manje često (≥ 1/1000 i < 1/100); rijetko (≥ 1/10 000 i < 1/1000); vrlo rijetko (< 1/10 000); nepoznato (ne može se procijeniti iz dostupnih podataka).
In addition, the corresponding frequency category for each adverse reaction is based on the following convention: very common (≥1/10); common (≥1/100 to <1/10); uncommon (≥1/1,000 to <1/100); rare (≥1/10,000 to <1/1,000); very rare (<1/10,000); not known (cannot be estimated from the available data).
Osim toga, odgovarajuća kategorija učestalosti za svaku nuspojavu određuje se na sljedeći način: vrlo često (≥ 1/10), često (≥ 1/100 i < 1/10), manje često (≥ 1/1000 i < 1/100), rijetko (≥ 1/10 000 i < 1/1000), vrlo rijetko (< 1/10 000), nepoznato (ne može se procijeniti iz dostupnih podataka).
In addition, the corresponding frequency category is provided using the following convention: Very common ( 1/10); Common ( 1/100 to < 1/10); Uncommon ( 1/1,000 to < 1/100); Rare ( 1/10,000 to < 1/1,000); Very rare (< 1/10,000).
Uz to, za svaku je nuspojavu navedena i odgovarajuća kategorija učestalosti prema sljedećem načelu: vrlo često ( 1/10); često ( 1/100 do < 1/10); manje često ( 1/1000 do < 1/100); rijetko ( 1/10 000 do < 1/1000); vrlo rijetko (< 1/10 000).
In addition, the corresponding frequency category using the following convention (CIOMS III) is also provided for each adverse drug reaction: very common (≥1/10); common (≥1/100 to <1/10); uncommon (≥1/1,000 to <1/100); rare (≥1/10,000 to <1/1,000); very rare (<1/10,000); not known: frequency cannot be estimated from the available data.
Uz to, za svaku je nuspojavu navedena i odgovarajuća kategorija učestalosti prema sljedećem načelu (CIOMS III): vrlo često (≥1/10); često (≥1/100 i <1/10); manje često (≥1/1000 i <1/100); rijetko (≥1/10 000 i <1/1000); vrlo rijetko (<1/10 000); nepoznato: učestalost se ne može procijeniti iz dostupnih podataka.
In addition, the development of antibodies against NovoSeven and FVII has been associated with overdose in one patient with factor VII deficiency.
Nadalje, razvoj protutijela na NovoSeven i FVII bio je povezan s predoziranjem u jednog bolesnika s nedostatkom faktora VII.
In addition, the difference in the percentage of patients demonstrating ≥ 20% improvement in PANSS total score at Week 26 between the two treatment groups was numerically similar.
Dodatno, razlika postotka bolesnika koji su pokazali poboljšanja ukupnog PANSS zbroja ≥ 20% u 26. tjednu za dvije liječene skupine bila je slična.
In addition, the disproportionality analyses scores in Food and Drug Administration (FDA) Adverse Event Reporting System (FAERS) and VigiBase databases suggests a potential association between aripiprazole and hiccups.
Uz to, rezultati analiza disproporcionalnosti u Sustavu prijave nuspojava Američke agencije za hranu i lijekove (FAERS) i bazama podataka VigiBase ukazuju na moguću povezanost između aripiprazola i štucavice.
In addition, the efficacy, safety and tolerability of Resolor in male patients with chronic constipation were evaluated in a 12-week, multi-centre, randomised, double-blind, placebo–controlled study (N=370).
Nadalje, djelotvornost, sigurnost i podnošljivost lijeka Resolor u muških bolesnika s kroničnom konstipacijom procijenjene su u 12-tjednom, multicentričnom, randomiziranom, dvostruko slijepom, placebom kontroliranom ispitivanju (N=370).
In addition, the following adverse reactions were reported during clinical trials with GlaxoSmithKline’s other combined hepatitis A and hepatitis B vaccines (given as a 3 or 4 dose schedule)
Nadalje, tijekom kliničkih ispitivanja s drugim kombiniranim cjepivima protiv hepatitisa A i hepatitisa B tvrtke GlaxoSmithKline (primijenjenih po rasporedu cijepljenja 3 ili 4 doze), prijavljene su sljedeće nuspojave
In addition, the following rare, serious adverse reactions have been reported in association with the use of NSAIDs and cannot be ruled out for Dynastat: bronchospasm and hepatitis.
Osim toga, za Dynastat se ne mogu isključiti ni sljedeće rijetke, ozbiljne nuspojave zabilježene u vezi s primjenom nesteroidnih protuupalnih lijekova: bronhospazam i hepatitis.
In addition, the following side effects have been identified during post-marketing experience.
Nadalje, sljedeće nuspojave su identificirane nakon stavljanja lijeka na tržište:
In addition, the following side effects have been seen after patients have taken ZYPREXA orally.
Osim toga, sljedeće su nuspojave primijećene u bolesnika koji su uzimali oralni oblik lijeka ZYPREXA.
In addition, the following uncommon (may affect up to 1 in 100 people) side effects have been reported in patients who received doses other than 3mg/kg of YERVOY in clinical trials:
Osim toga, sljedeće manje česte nuspojave (mogu se javiti u do 1 na 100 osoba) prijavljene su u bolesnika koji su primali drugačije doze od 3mg/kg lijeka YERVOY u kliničkim ispitivanjima:
In addition, the immunogenicity has also been evaluated in a Phase 3 study in specified risk groups of immunocompromised subjects (N=122) and patients with chronic disease conditions (N=123) following a 0, 21 day schedule.
Nadalje, imunogenost je također procijenjena u fazi 3 ispitivanja, u specifičnim rizičnim skupinama imunokompromitiranih ispitanika (N=122) i bolesnika s kroničnim bolestima (N=123) nakon primjene 0. i 21. dana.
In addition, the MAH should discuss any further outcome data on the combination of bevacizumab + erlotinib in this indication (e.g. data from the ongoing ACCRU
Osim toga, nositelj odobrenja mora dostaviti i sve daljnje podatke o ishodima ostvarenima uz kombinirano liječenje bevacizumabom + erlotinibom u navedenoj
In addition, the MAH will submit the second interim safety analysis of the phase III study JGDJ.
Osim toga, nositelj odobrenja treba dostaviti i drugu interim analizu sigurnosti za ispitivanje faze III (JGDJ).
In addition, the observed trough nevirapine concentrations were comparable between the two methods.
Nadalje, opažene koncentracije nevirapina na kraju doziranog intervala bile su usporedive među dvjema metodama.
In addition, the Patient Card explains the need for monitoring of liver function and educates the patient on the importance of adherence to their monthly blood tests
Osim toga, Kartica za bolesnika objašnjava potrebu za praćenjem funkcije jetre i podučava bolesnika o važnosti pridržavanja provođenja mjesečnih krvnih testova.
In addition, the patients who took Daxas had an average of 1.1 moderate or severe flare-ups of their disease, compared with 1.4 flare-ups in the patients who took placebo.
Osim toga, kod bolesnika koji su uzimali Daxas u prosjeku je zabilježeno 1,1 umjereno ili teško izbijanje njihove bolesti u usporedbi s prosjekom izbijanja od 1,4 kod bolesnika koji su uzimali placebo.
In addition, the pharmacokinetic-pharmacodynamic models show no exposure-effect relationship, with an estimated QTcF mean change of –6.4 ms (upper confidence interval –0.9 ms) at Cmax for the 60 mg group.
Pored toga, farmakokinetički-farmakodinamički modeli nisu pokazali odnos izloženosti-učinka s procijenjenom prosječnom promjenom QTcF od -6,4 ms (gornji interval pouzdanosti -0,9 ms) pri Cmax za skupinu od 60 mg.
In addition, the pharmacokinetic-pharmacodynamic models show no exposure-effect relationship, with an estimated QTcF mean change of –6.4 ms (upper confidence interval –0.9 ms) at Cmax for the 60 mg group.
Pored toga, farmakokinetički-farmakodinamički modeli nisu pokazali odnos izloženosti-učinka s procijenjenom prosječnom promjenom QTcF od -6,4 ms (gornji interval pouzdanosti-0,9 ms) pri Cmax za skupinu od 60 mg.
In addition, the post-marketing reports with Oncaspar that include spontaneous reports as well as serious adverse events from clinical studies.
Osim toga, uzete su u obzir prijave nakon stavljanja lijeka u promet s Oncasparom koje obuhvaćaju spontane prijave, kao i ozbiljni štetni događaji iz kliničkih ispitivanja.
In addition, the powder will dissolve more readily if both vials are first allowed to reach room temperature (15°C – 25°C).
Osim toga, prašak će se bolje otopiti ako se obje bočice najprije ostave da se zagriju na sobnu temperaturu (15 °C – 25 °C).
In addition, the product was shown to be effective against 4th stage larvae of a strain of H. contortus in a laboratory study where a combination of abamectin with derquantel was not effective.
Osim toga, proizvod se pokazao učinkovit protiv 4. stupnja larvi soja H. contortus u laboratorijskom ispitivanju u kojem kombinacija abamektina s derkvantelom nije bila učinkovita.
In addition, the results indicated that Jardiance treatment was associated with a beneficial fall in body weight and blood pressure.
Pored toga, rezultati su ukazali da je liječenje lijekom Jardiance povezano s korisnim smanjenjem tjelesne težine i krvnog tlaka.
In addition, the results indicated that the combination was associated with a beneficial decrease in body weight and blood pressure.
Nadalje, rezultati ukazuju na to da je ta kombinacija povezana s korisnim snižavanjem tjelesne težine i krvnoga tlaka.
In addition, the risk of seizure may be increased in patients receiving concomitant medicinal products that lower the seizure threshold.
Osim toga, rizik od napadaja može biti povećan u bolesnika koji istovremeno primaju lijekove koji snižavaju prag za napadaje.
In addition, the safety of the medicine was considered acceptable.
Nadalje, zaključeno je da je sigurnosni profil lijeka prihvatljiv.
In addition, the safety of the medicine was considered acceptable.
Nadalje, zaključeno je da je sigurnost lijeka prihvatljiva.
In addition, the selection of L74V and K65R was reduced when co-administered with ZDV (K65R: without ZDV: 13/127, 10 %; with ZDV: 1/86, 1 %; L74V: without ZDV: 51/127, 40 %; with ZDV: 2/86, 2 %).
Dodatno, selekcija L74V i K65R se smanjuje kada se daje zajedno sa ZDV (K65R: bez ZDV: 13/127, 1%; sa ZDV: 1/86, 1%; L74V: bez ZDV: 51/127, 40%; L74V: sa ZDV: 2/86, 2%).
In addition, the side effects listed below have occurred in the days or weeks after vaccination with vaccines given routinely every year to prevent flu.
Osim toga, niže navedene nuspojave pojavile su se u danima ili tjednima nakon cijepljenja cjepivima koja se rutinski daju svake godine radi sprječavanja gripe.
In addition, the side effects listed below have occurred in the days or weeks after vaccination with vaccines given routinely every year to prevent seasonal flu.
Osim toga, niže navedene nuspojave pojavile su se u danima ili tjednima nakon cijepljenja cjepivima koja se rutinski daju svake godine radi sprječavanja sezonske influence.
In addition, the table shows the subset of the composite NPS AE endpoint of severe intensity:
Pored toga, tablica prikazuje kompozitnu mjeru ishoda NPS štetnih događaja teškog intenziteta:
In addition, the usefulness of Neuraceq in predicting the development of Alzheimer’s disease in patients with memory problems or in monitoring patients’ response to treatment has not been established.
Nadalje, nije utvrđena primjenjivost lijeka Neuraceq u predviđanju razvoja Alzheimerove bolesti u bolesnika s problemima s pamćenjem ili u praćenju odgovora bolesnika na liječenje.
In addition, the usefulness of Vizamyl in predicting the development of Alzheimer’s disease in patients with memory problems or in monitoring patients’ response to treatment has not been established.
Nadalje, iskoristivost lijeka Vizamyl u predviđanju razvoja Alzheimerove bolesti u bolesnika s problemima pamćenja ili praćenju odgovora bolesnika na liječenje nije utvrđeno.
In addition, there are certain signs and symptoms that you should look out for yourself.
Osim toga, postoje određeni znakovi i simptomi na čiju biste pojavu i sami trebali obratiti pozornost.
In addition, there have been few reports (<1%), some fatal, of subjects presenting with seizures and radiological evidence of reversible posterior leukoencephalopathy syndrome (RPLS).
Osim toga, postoje malobrojna izvješća (< 1%) neka i fatalna, o ispitanicima kod kojih su se javili napadaji s radiološki potvrđenim sindromom reverzibilne posteriorne leukoencefalopatije (engl. reversible posterior leukoencephalopathy syndrome, RPLS).
In addition, there have been reported cases of burns, including second degree burns, in patients treated with capsaicin patches.
Dodatno su zabilježeni i slučajevi opekotina, uključujući opekotine drugog stupnja, u bolesnika liječenih flasterima s kapsaicinom.
In addition, there is a potential for a pharmacodynamic interaction to occur during co- administration due to additive renal effects.
Osim toga, pri istodobnoj primjeni postoji i mogućnost farmakodinamičke interakcije zbog dodatnih učinaka na bubrege.
In addition, there is experimental evidence that Defibrotide may protect the cells lining blood vessels.
Nadalje, postoji eksperimentalan dokaz da defibrotid može zaštititi stranice unutarnje prevlake krvnih žila.
In addition, there is post-marketing experience in over 866,000 Asian (mainly Japanese) patients.
Dodatno postoji post-marketinško iskustvo na preko 866 000 azijskih bolesnika (pretežno Japanaca).
In addition, there was a statistically significant effect on 24 week confirmed disability progression in Zinbryta treated patients with a hazard ratio 0.73 [95% CI: 0.55, 0.98].
Osim toga, u bolesnika liječenih Zinbrytom došlo je do statistički značajnog učinka na potvrđenu progresiju onesposobljenosti tijekom 24 tjedna s omjerom hazarda od 0,73 [95% CI: 0,55; 0,98].
In addition, there was no clinically significant effect of the low dose combination oral contraceptive pill on the pharmacokinetics of retigabine.
Nadalje, nije bilo klinički značajnog učinka tablete niskodoznih kombiniranih oralnih kontraceptiva na farmakokinetiku retigabina.
In addition, there was no statistically significant increased risk of this adverse event during the 0-30 day follow-up period compared with a concurrent control group of infants who received DTaP, but not RotaTeq (n=62,617, 12,339 person-years of follow-up).
Nadalje, rizik od ove nuspojave nije bio statistički značajno povećan tijekom prvih 0-30 dana praćenja u usporedbi s onim u kontrolnoj skupini dojenčadi koja je u tom razdoblju primila DTaP, ali ne i RotaTeq (n=62 617, 12 339 osoba- godina praćenja).
In addition, these events can also be managed by withholding bosutinib temporarily, dose reduction, and/or discontinuation of bosutinib (see sections 4.2 and 4.8).
Nadalje, ti se događaji mogu također zbrinjavati privremenim prekidom liječenja bosutinibom, smanjivanjem doze i/ili trajnim prekidom liječenja bosutinibom (vidjeti dijelove 4.2 i 4.8).
In addition, these events can also be managed by withholding bosutinib temporarily, dose reduction, and/or discontinuation of bosutinib (see sections 4.2 and 4.8).
Nadalje, ti se događaji mogu također zbrinuti privremenim prekidom bosutiniba, smanjivanjem doze i/ili trajnim prekidom liječenja bosutinibom (vidjeti dijelove 4.2 i 4.8).
In addition, thirty-nine cases of bradycardia (eight of which were assessed as serious, the remainder as non-serious) were reported from alemtuzumab post-marketing reports as of 01 May 2015.
Dodatno, trideset i devet slučajeva bradikardije (od kojih je osam ocijenjeno kao ozbiljni, a ostali kao ne-ozbiljni) prijavljeni su u izvješćima nakon stavljanja lijeka alemtuzumab u promet od 1.svibnja 2015.
In addition, three impact studies on all cause diarrhoea hospitalisation conducted in Latin America showed a reduction of 29% to 37% two years after vaccine introduction.
Uz to, tri ispitivanja utjecaja na hospitalizaciju zbog proljeva bilo kojeg uzroka provedena u Južnoj Americi pokazala su smanjenje od 29% do 37% dvije godine nakon uvođenja cjepiva.
In addition, thrombocythaemia above the normal range has been reported.
Pored toga, zabilježena je i trombocitemija iznad normalnog raspona.
In addition, to support its application, the company performed a ‘bioequivalence’ study comparing Odefsey with two other HIV medicines: Edurant (rilpivirine) and Genvoya (elvitegravir, cobicistat, emtricitabine and tenofovir alafenamide).
Kako bi poduprla svoj zahtjev, tvrtka je, osim toga, provela ispitivanje „bioekvivalencije” u kojem je usporedila lijek Odefsey s drugim dvama lijekovima za liječenje HIV-a, lijekom Edurant (rilpivirin) i lijekom Genvoya (elvitegravir, kobicistatom, emtricitabin i tenofoviralafenamid).
In addition, transient increases in serum potassium and phosphate levels have been observed in isolated cases (see section 4.4).
Pored toga, u izoliranim slučajevima zapažen je prolazni porast koncentracija kalija i fosfata u serumu (vidjeti dio 4.4).
In addition, treatment with a combination of Volibris (10 mg) and tadalafil has been compared with either Volibris or tadalafil alone in another main study involving 605 patients with PAH.
Usto, liječenje kombinacijom Volibrisa (10 mg) i tadalafila uspoređeno je s Volibrisom ili tadalafilom pojedinačno u drugom glavnom ispitivanju koje je obuhvaćalo 605 pacijenata koji boluju od PAH-a.
In addition, two large observational studies designed to assess the safety of Focetria exposure in pregnancy showed no increase in the rates of gestational diabetes, preeclampsia, abortions, stillbirth, low birth weight, prematurity, neonatal deaths, and congenital malformations among almost 10.000 vaccinated pregnant women and their offspring compared with unvaccinated controls.
Osim toga, dvije velike opservacijske studije za procjenjivanje sigurnosti cijepljenja cjepivom Focetria tijekom trudnoće nisu pokazale povećanje stope gestacijskog dijabetesa, preeklampsije, pobačaja, mrtvorođene djece, djece niske porođajne težine, prerano rođene djece, novorđenačke smrti i kongenitalnih malformacija kod gotovo 10 000 cijepljenih trudnica i njihovog potomstva uspoređeno s necijepljenom kontrolnom skupinom.
In addition, vaccine immunogenicity was comparable among breast-feeding mothers and women who did not breastfeed during the vaccine administration.
Dodatno, imunogenost cjepiva je bila usporediva između majki dojilja i majki koje nisu dojile za vrijeme cijepljenja.
In addition, vaccine immunogenicity was comparable among breastfeeding mothers and women who did not breastfeed during the vaccine administration.
Dodatno, imunogenost cjepiva je bila usporediva između majki dojilja i majki koje nisu dojile za vrijeme cijepljenja.
In addition, virologic response was observed in 91% (21/23), 71% (15/21) and 33% (2/6) patients with 0 − 5, 6 − 7, and 8 − 10 mutations of the above mutations in HIV protease associated with reduced in vitro susceptibility to lopinavir.
Uz to, virološki je odgovor uočen u, redom, 91% (21/23), 71% (15/21) i 33% (2/6) bolesnika s 0 − 5, 6 − 7 i 8 − 10 gore navedenih mutacija proteaze HIV-a povezanih sa smanjenom osjetljivošću na lopinavir in vitro.
In addition, virus resistance to Sovaldi is very uncommon and Sovaldi works against all types of hepatitis C virus.
Nadalje, otpornost virusa na lijek Sovaldi vrlo je rijetka, pa je lijek Sovaldi djelotvoran protiv svih tipova virusa hepatitisa C.
In addition, we do not know how Revlimid affects the chances of you getting AML.
Još se ne zna kako Revlimid utječe na mogućnost da dobijete akutnu mijeloičnu leukemiju.
In addition, when bleeding did occur, Elocta treatment was rated as ‘excellent’ or ‘good’ in more than 78% of cases, with 87% of bleeding episodes resolving with only one injection.
Usto je, čak i kad je došlo do krvarenja, liječenje lijekom Elocta ocijenjeno kao „izvrsno” ili „dobro” u više od 78 % slučajeva, pri čemu je 87 % slučajeva krvarenja riješeno samo jednom injekcijom.
In addition, when Bortezomib Accord is given in combination with other chemotherapeutic medicinal products, appropriate dose reductions for these products should be considered in the event of toxicities according to the recommendations in the Summary of Product Characteristics.
Dodatno, kad se Bortezomib Accord primjenjuje u kombinaciji s ostalim kemoterapeuticima, u slučaju toksičnosti u obzir se moraju uzeti prikladne redukcije doza tih lijekova, u skladu s preporukama iz Sažetka opisa svojstava lijeka.
In addition, when CRIXIVAN is given at the same time as the medicine ritonavir:
Nadalje, kada se CRIXIVAN primjenjuje istodobno s ritonavirom:
In addition, women taking DUAVIVE should be advised to move about periodically during travel involving prolonged immobilisation.
Osim toga, žene koje uzimaju DUAVIVE treba savjetovati da se kreću periodično tijekom putovanja koje je povezano s produljenom imobilizacijom.
In addition, women taking the combination survived for 14 months on average, compared with 9.5 months in those taking Tyverb alone.
Nadalje, žene koje su uzimale kombinaciju preživjele su prosječno 14 mjeseci, u usporedbi s 9,5 mjeseci u onih koje su uzimale monoterapiju lijekom Tyverb.
In addition, Xalkori was investigated in patients who had not received treatment for their NSCLC before.
Osim toga, Xalkori je ispitan i u bolesnika koji prethodno nisu primili terapiju protiv NSCLC-a.
In addition, you will receive electrocardiograms twice weekly.
Pored toga podvrgnut ćete se elektrokardiogramu dva puta tjedno.
In addition, your blood will be tested for specific viruses (for example HIV-1, HIV-2, hepatitis B and hepatitis C).
Osim toga, Vašu će krv testirati na specifične viruse (primjerice HIV-1, HIV-2, hepatitis B i hepatitis C).
In addition, Zevalin is not recommended for the use in patients with non-Hodgkin’s lymphoma involving the brain and/or spinal cord as those patients were not included in clinical studies.
Zevalin se, k tome, ne preporučuje za primjenu na bolesnicima s ne-Hodgkinovim limfomom koji je zahvatio mozak i/ili leđnu moždinu jer takvi bolesnici nisu bili uključeni u klinička ispitivanja.
In addition, Zinbryta reduced clinically meaningful worsening in the patient- reported physical impact of MS (≥7.5 point worsening from baseline to week 96 in the MSIS-29 physical score) compared to interferon beta-1a (intramuscular).
Osim toga, Zinbryta je smanjila klinički značajno pogoršanje fizičkog učinka MS-a kojeg su izvijestili bolesnici (pogoršanje od ≥7,5 bodova od početne vrijednosti do 96. tjedna prema fizičkoj ocjeni ljestvice MSIS-29) u usporedbi s interferonom beta-1a (intramuskularno).
In addition,dry mouth that could have a damaging effect on teeth and membranes of the mouth has been reported during long-term treatment with this medicine in combination therapy with and alpha interferon.
Nadalje, tijekom dugotrajne kombinirane terapije lijekom ovim lijekom i alfa interferonom prijavljena je i suhoća usta koja može štetno djelovati na zube i sluznicu usta.
In additional extension trials, patients receiving elosulfase alfa 2 mg/kg every week, showed maintenance of initial improvement in endurance and sustained reduction of urinary KS up to 156 weeks.
U dodatnim produžetcima ispitivanja, bolesnici koji su primili elosulfazu alfa u dozi 2 mg/kg svaki tjedan, pokazali su održavanje početnog poboljšanja izdržljivosti i održanom smanjenju KS-a u mokraći u trajanju do 156 tjedana.
In adolescents (12-17 years) relative change in % predicted FEV1 compared to control improved by 3.31% (95% CI -2.29, 8.90, N=55) and 0.42% (95% CI -5.45, 6.29, N=94) over 26 weeks (p=0.245 and 0.888) respectively.
U usporedbi s kontrolnom skupinom, procijenjena relativna promjena % FEV1 u adolescenata (u dobi od 12 do 17 godina) poboljšala se za 3,31% (95% CI -2,29, 8,90, N = 55) i 0,42% (95% CI -5,45, 6,29,
In adolescents (aged from 12 to 17 years and weighing at least 40 kg) infected with HIV-1 without resistance to the integrase class, the recommended dose of dolutegravir is 50 mg once daily.
U adolescenata (u dobi od 12 do 17 godina i tjelesne težine od najmanje 40 kg) zaraženih virusom HIV-1 bez rezistencije na skupinu inhibitora integraze, preporučena doza dolutegravira je 50 mg jedanput na dan.